{"id":"W2038349091","doi":"10.1016/j.ejca.2011.09.002","title":"Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Internal medicine; Cancer research; Oncology; Cancer; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003351003,0.0002321933,0.0005362901,0.0002225696,0.00001822389,0.000007702946,0.0001497931,0.00003145287,0.0009303806],"category_scores_gemma":[0.0000263651,0.0001553204,0.0001628763,0.0002067663,0.00008436363,0.0001602621,0.00002867133,0.0003680522,0.000008527017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001610459,"about_ca_system_score_gemma":0.0002896119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004327689,"about_ca_topic_score_gemma":0.00006278692,"domain_scores_codex":[0.9979591,0.000225439,0.0008025636,0.0001949645,0.0005555794,0.0002623363],"domain_scores_gemma":[0.9981927,0.00002498266,0.0007585394,0.0002477252,0.0005459689,0.0002301452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7411074,0.007764436,0.1288506,0.000244411,0.0006016577,0.003957056,0.005057563,0.0001147222,0.004910774,0.000003714234,0.001186621,0.106201],"study_design_scores_gemma":[0.4494948,0.03708301,0.4584138,0.001714803,0.0007327851,0.00002748464,0.0001761661,0.000002684718,0.04063709,0.000004428945,0.01135597,0.0003568852],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927828,0.001437896,0.00001538284,0.00009905177,0.000299613,0.0004797758,0.00003679152,0.000006425735,0.004842225],"genre_scores_gemma":[0.9973758,0.0002178002,0.001437624,0.0001248311,0.0003741475,0.00001498178,0.000005820675,0.00006392613,0.0003850419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3295632,"threshold_uncertainty_score":0.9999829,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02376342824592086,"score_gpt":0.2733685222410839,"score_spread":0.249605093995163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}